Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.
Northwestern Medicine scientists have discovered why Huntington’s is so toxic to cancer cells and harnessed it for a novel approach to treat cancer, a new study reports.
Huntington’s is caused by an over abundance of a certain type of repeating RNA sequences in one gene, huntingtin, present in every cell. The defect that causes the disease also is highly toxic to tumor cells. These repeating sequences — in the form of so-called small interfering RNAs — attack genes in the cell that are critical for survival. Nerve cells in the brain are vulnerable to this form of cell death, however, cancer cells appear to be much more susceptible.
“This molecule is a super assassin against all tumor cells,” said senior author Marcus Peter, the Tom D. Spies Professor of Cancer Metabolism at Northwestern University Feinberg School of Medicine. “We’ve never seen anything this powerful.”
Huntington’s disease deteriorates a person’s physical and mental abilities during their prime working years and has no cure.
The study will be published Feb. 12 in the journal EMBO Reports.
To test the super assassin molecule in a treatment situation, Peter collaborated with Dr. Shad Thaxton, associate professor of urology at Feinberg, to deliver the molecule in nanoparticles to mice with human ovarian cancer. The treatment significantly reduced the tumor growth with no toxicity to the mice, Peter said. Importantly, the tumors did not develop resistance to this form of cancer treatment.
Peter and Thaxton are now refining the delivery method to increase its efficacy in reaching the tumor. The other challenge for the scientists is figuring out how to stabilize the nanoparticles, so they can be stored.
First and co-corresponding author Andrea Murmann, research assistant professor in medicine at Feinberg, also used the molecule to treat human and mouse ovarian, breast, prostate, liver, brain, lung, skin and colon cancer cell lines. The molecule killed all cancer cells in both species.
The Huntington’s cancer weapon was discovered by Murmann, who had worked with Peter on earlier research that identified an ancient kill-switch present in all cells that destroys cancer.
“I thought maybe there is a situation where this kill switch is overactive in certain people, and where it could cause loss of tissues,” Murmann said. “These patients would not only have a disease with an RNA component, but they also had to have less cancer.”
She started searching for diseases that have a lower rate of cancer and had a suspected contribution of RNA to disease pathology. Huntington’s was the most prominent.
When she looked at the repeating sequences in huntingtin, the gene that causes the disease, she saw a similar composition to the earlier kill switch Peter had found. Both were rich in the C and G nucleotides (molecules that form the building blocks of DNA and RNA).
“Toxicity goes together with C and G richness,” Murmann said. “Those similarities triggered our curiosity.”
In the case of people who have Huntington’s, the gene huntingtin has too many repeating sequences of the triplet sequence CAG. The longer the repeating sequence, the earlier they will develop the disease.
“We believe a short-term treatment cancer therapy for a few weeks might be possible, where we could treat a patient to kill the cancer cells without causing the neurological issues that Huntington’s patients suffer from,” Peter said.
Peter also is co-leader of the Translational Research in Solid Tumors Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Huntington’s patients have a lifetime exposure to these toxic RNA sequences, but generally don’t develop symptoms of the disease until age 40, he noted.
Every child of a parent with Huntington’s has 50/50 chance of carrying the faulty gene. Today, there are approximately 30,000 symptomatic Americans and more than 200,000 at-risk of inheriting the disease.
Learn more: Huntington’s disease provides new cancer weapon
The Latest on: Cancer therapy
- US Sanctions on Iran Depriving Country’s Cancer Patients of Essential Treatment on November 14, 2018 at 10:25 am
TEHRAN, IRAN – The recent imposition of crippling sanctions against Iran by the United States government has made life increasingly difficult for everyday Iranians, as essential supplies are becoming ... […]
- Mercy Health partners with OSU on cancer, transplants, addiction treatment on November 14, 2018 at 9:37 am
Cincinnati-based Mercy Health disclosed today that it is partnering with Ohio State University’s Wexner Medical Center to address critical health needs throughout the state, including the opioid epide... […]
- The Huntsman Cancer Institute will name a new therapy center after Utah Sen. Orrin Hatch on November 14, 2018 at 9:24 am
The Huntsman Cancer Institute at the University of Utah will name its newest, soon-to-be-built therapy center after retiring Republican Sen. Orrin Hatch. The U.’s board of trustees unanimously approve... […]
- Advances in the treatment of triple-negative breast cancer on November 14, 2018 at 9:20 am
The death rate from breast cancer in 1989 was 33.2 per 100,000 women, according to the American Cancer Society Flash forward to 2015 when the death rate plummeted 39 percent to 20.3. The improvement i... […]
- Cancer treatment facility to be named for retiring Sen. Orrin Hatch on November 14, 2018 at 9:18 am
SALT LAKE CITY — The Huntsman Cancer Institute's proton therapy center will be named in honor of Sen. Orrin Hatch, R-Utah. The University of Utah board of trustees on Tuesday approved a $10 million gi... […]
- New Approaches to Localized Prostate Cancer Combat Overtreatment on November 14, 2018 at 8:46 am
Both the diagnosis and treatment of patients with localized prostate cancer have recently been re-evaluated in an effort to address overtreatment. According to Mark Emberton, MD, FRCS, the most import... […]
- Constance Alexander: Music at the heart of Norton Cancer Center therapy helping patients find joy on November 14, 2018 at 7:34 am
Google “heartbeat sounds” and you’ll find an array of audio and video possibilities, ranging from a mere minute to a full twelve hours of lub-dub, lub-dub. There are soporific pulsations to pamper bab... […]
- Two genomic tests help identify most effective treatment for breast cancer patients on November 14, 2018 at 7:27 am
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly ... […]
- First blood-based biomarker in response to the treatment of the most aggressive prostate cancer on November 14, 2018 at 6:18 am
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated via two therapies: taxanes or hormone treatment. Until recently, there were no comparative studies ... […]
- FDA approves new ‘game-changer’ cancer treatment on November 13, 2018 at 11:32 pm
MEMPHIS, TN (WMC) - The FDA has approved a new cancer treatment that is being used in the Bluff City. Doctors are convinced it could even cure some forms of cancer. This new cancer treatment is being ... […]
via Google News and Bing News